Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This review aimed to specify different concepts that are essential to the development of medical devices (MDs) with artificial intelligence (AI) (AI-based MDs) and shed light on how algorithm performance, interpretability, and explainability are key assets. First, a literature review was performed to determine the key criteria needed for a health technology assessment of AI-based MDs in the existing guidelines. Then, we analyzed the existing assessment methodologies of the different criteria selected after the literature review. The scoping review revealed that health technology assessment agencies have highlighted different criteria, with 3 important ones to reinforce confidence in AI-based MDs: performance, interpretability, and explainability. We give recommendations on how and when to evaluate performance on the basis of the model structure and available data. In addition, should interpretability and explainability be difficult to define mathematically, we describe existing ways to support their evaluation. We also provide a decision support flowchart to identify the anticipated regulatory requirements for the development and assessment of AI-based MDs. The importance of explainability and interpretability techniques in health technology assessment agencies is increasing to hold stakeholders more accountable for the decisions made by AI-based MDs. The identification of 3 main assessment criteria for AI-based MDs according to health technology assessment guidelines led us to propose a set of tools and methods to help understand how and why machine learning algorithms work as well as their predictions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11975643PMC
http://dx.doi.org/10.1016/j.mcpdig.2023.02.004DOI Listing

Publication Analysis

Top Keywords

ai-based mds
24
interpretability explainability
16
health technology
16
technology assessment
16
performance interpretability
12
assessment
8
literature review
8
assessment ai-based
8
assessment agencies
8
mds
7

Similar Publications

Myelodysplastic syndrome / neoplasm (MDS) presents a diagnostic challenge due to the need of expert morphological analysis, and the reliance on genomic analysis of collected bone marrow material for the definite diagnosis. This study aimed to facilitate this process by developing a computer vision AI-based model that is capable of diagnosing MDS from images from peripheral blood smears (PBS). We used a cohort of 43,371 neutrophils from 84 MDS and 60 non-MDS samples to train a neutrophil classifier to differentiate between dysplastic and non-dysplastic cells.

View Article and Find Full Text PDF

Advances in genomic medicine accelerate the identification of mutations in disease-associated genes, but the pathogenicity of many mutations remains unknown, hindering their use in diagnostics and clinical decision-making. Predictive AI models are generated to combat this issue, but current tools display low accuracy when tested against functionally validated datasets. We show that integrating detailed conformational data extracted from molecular dynamics simulations (MDS) into advanced AI-based models increases their predictive power.

View Article and Find Full Text PDF

Background: Differentiating between stage 1 or 2 pressure ulcer/pressure injury (PU/PI) and incontinence-associated dermatitis (IAD) poses a significant challenge for healthcare professionals, due to their visual similarity. Incorrect assessments may trigger inappropriate interventions, potentially resulting in delayed treatment. KIADEKU is a multi-center research project aimed at supporting the assessment and documentation of PU/PI and IAD, as well as the implementation of evidence-based care through an AI-based application in nursing care.

View Article and Find Full Text PDF

Development of oral, broad-spectrum therapeutics targeting SARS-CoV-2, its variants, and related coronaviruses could curb the spread of COVID-19 and avert future pandemics. We created a novel computational discovery pipeline that employed molecular dynamics simulation (MDS), artificial intelligence (AI)-based docking predictions, and medicinal chemistry to design viral entry inhibitors that target a conserved region in the SARS-CoV-2 spike (S) protein that mediates membrane fusion. DrugBank library screening identified the orally available, FDA-approved AXL kinase inhibitor bemcentinib as binding this site and we demonstrated that it inhibits viral entry in a kinase-independent manner.

View Article and Find Full Text PDF

BackgroundClinical assessments of motor symptoms rely on observations and subjective judgments against standardized scales, leading to variability due to confounders. Improving inter-rater agreement is essential for effective disease management.ObjectiveWe developed an objective rating system for Parkinson's disease (PD) that integrates computer vision (CV) and machine learning to correct potential discrepancies among raters while providing the basis for model performance to gain professional acceptance.

View Article and Find Full Text PDF